Michael Hunt is CEO of the Imperial College London-based start-up NK:IO. In this episode, he tells us about his journey from accounting into the life sciences and how he became involved in the cell therapy space.

We discuss the challenges facing innovative start-ups like NK:IO in this competitive field and why their technology presents a unique solution to fighting solid tumours. Michael also shares his reasons for taking on the CEO role in an early-stage company where risk is prevalent.